Harvard Bioscience's market cap is currently $51.47M. The company's EPS TTM is $-0.328; its P/E ratio is ―; Harvard Bioscience is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $0.05. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 112.25M	$ 113.33M	$ 118.90M	$ 102.10M	$ 116.18M
Gross Profit	$ 66.07M	$ 60.82M	$ 67.65M	$ 58.04M	$ 64.32M
Operating Income	$ 1.89M	$ -7.17M	$ 1.40M	$ -585.00K	$ 1.47M
EBITDA	$ 8.03M	$ 944.00K	$ 11.31M	$ 5.49M	$ 7.50M
Net Income	$ -3.42M	$ -9.52M	$ -288.00K	$ -7.81M	$ -4.69M
Balance Sheet
Cash & Short-Term Investments	$ 4.28M	$ 4.51M	$ 7.82M	$ 8.32M	$ 8.34M
Total Assets	$ 137.37M	$ 145.36M	$ 162.34M	$ 156.25M	$ 164.87M
Total Debt	$ 42.77M	$ 46.82M	$ 48.33M	$ 48.01M	$ 53.82M
Net Debt	$ 38.49M	$ 42.32M	$ 40.51M	$ 39.69M	$ 45.48M
Total Liabilities	$ 64.29M	$ 73.14M	$ 78.94M	$ 79.57M	$ 83.18M
Stockholders' Equity	$ 73.07M	$ 72.22M	$ 83.40M	$ 76.68M	$ 81.69M
Cash Flow
Free Cash Flow	$ 11.72M	$ -438.00K	$ -83.00K	$ 8.18M	$ 6.83M
Operating Cash Flow	$ 14.03M	$ 1.15M	$ 1.26M	$ 9.33M	$ 8.05M
Investing Cash Flow	$ -1.80M	$ -1.59M	$ -1.34M	$ -1.40M	$ -229.00K
Financing Cash Flow	$ -12.13M	$ -2.84M	$ -252.00K	$ -7.97M	$ -7.63M

Currency in USD

Harvard Bioscience Earnings and Revenue History

Income Statement >

Harvard Bioscience Debt to Assets

Balance Sheet >

Harvard Bioscience Cash Flow

Cash Flow >

Harvard Bioscience Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing